SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (1184)1/14/2000 2:20:00 AM
From: scaram(o)uche  Respond to of 2001
 
I just read the TechVest comments (thanks, WD). Silly.

Do they really think FDA is going to approve an anti-adhesion gel without data to support patient benefit?

Bad news for LifeCore is bad news for Gliatech and it is bad
news for anyone developing a postoperative adhesion (POA) product for pelvic or gynecological applications.


Yes, all of the agents will have identical efficacy, and all of the trials will share a common design. Not!

Sometimes the human mind just stops working when someone waves money in front of it.